Posts

Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23)

Never Too Late: If you missed the IPKat last week!

Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide)

[GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings

G 2/21 applied to software inventions (T 0687/22)

EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation"

A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22)

No delay following an intervention to an accelerated EPO appeal during parallel UPC proceedings (T 1841/23)